张化桥 顾问专家

张化桥先生现为香港上市公司中国支付通董事長,兼任绿叶制药和复星医药的母公司复星国际、中国石化石油服务公司和万达酒店独立董事。张先生在香港资本市场工作23年,担任瑞士銀行研究部主管和投資銀行副主管。张先生1986年毕业于中国人民银行五道口研究生部,随后在央行工作。1989-1990年留学澳大利亚国立大学,获经济学硕士学位。

Huaqiao Zhang
Expert Advisor

Mr. Zhang is serving as Chairman of China Smartpay, a company going public in Hong Kong. He is concurrently serving as an independent director of Fosun, the parent company of Luye Pharma and Fosun Pharma, Sinopec International Petroleum Service Corporation and Wanda Hotel. Mr. Zhang has worked in capital markets in Hong Kong for 23 years, as Supervisor of the Research Department and Deputy Supervisor of Investment Banking of UBS. Mr. Zhang graduated from the Wudaokou Graduates Department of People’s Bank of China in 1986 and afterwards worked at People’s Bank of China. From 1989 to 1990, Mr. Zhang studied at the Australian National University and received a master’s degree in economics.